BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Staging
5 results:

  • 1. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis.
    Liu J; Shen B; Yang Y; Guo J; Ren W; Zhou Q; Mao J; Ye W; Wu D
    Acta Oncol; 2023 Mar; 62(3):305-314. PubMed ID: 37010509
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.
    Soldatelli JS; Oliveira IM; Kneubil MC; Henriques JAP
    An Acad Bras Cienc; 2022; 94(3):e20211075. PubMed ID: 35766600
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung cancer.
    Bogart JA; Waqar SN; Mix MD
    J Clin Oncol; 2022 Feb; 40(6):661-670. PubMed ID: 34985935
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
    Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
    Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
    Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.